MedDataX Logo

Diagnosis-related Outcomes in NeurocriTical Care: Prognostic Estimate by Health-care Providers Versus Risk Scores in Intracerebral and Subarachnoid Hemorrhage

NCT ID: NCT04063982

Last Updated: 2023-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-12

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the observational multicenter trial encompasses the comparison of estimation of the long-term prognosis (functional and cognitive outcomes, quality of life) after intracerebral and subarachnoid hemorrhages assessed by clinical scores, treating physicians and nurses. The scores and the assessment of the treating physicians and nurses are recorded on admission, at 7 and 14 days after symptom onset.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The physicians and nurses responsible for the individual patient's care will be given a questionaire. They are asked to estimate the functional and cognitive status as well as quality of life of their patient. The patient with intracerebral hemorrhage and subarachnoid hemorrhage is examined and assessed with respective established and validated prognostic scores and models at the same time points.

The actual prognosis is assessed by telephone interview and questionaires at 3 and 6 months, either from the patient or his/her caretaker.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracerebral Hemorrhage Subarachnoid Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

none, only assessment at different time points

assessment at different time points

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Spontaneous intracerebral hemorrhage or nontraumatic subarachnoid hemorrhage
* Treatment in Centers with neurocritical care expertise

Exclusion Criteria

* Language other than German and English
* Restriction of diagnostic and therapeutic measures during acute hospitalization according to advanced directives
* Admission \> 48 hours after symptom onset
* Hemorrhage due to trauma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

German Society of Neurocritical Care

UNKNOWN

Sponsor Role collaborator

University of Leipzig

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Katja E Wartenberg, MD

Role: PRINCIPAL_INVESTIGATOR

University of Leipzig

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité University Hospital

Berlin, , Germany

Site Status ACTIVE_NOT_RECRUITING

University Hospital of Duesseldorf

Düsseldorf, , Germany

Site Status RECRUITING

University of Frankfurt

Frankfurt, , Germany

Site Status RECRUITING

Wolf-Dirk Niesen

Freiburg im Breisgau, , Germany

Site Status ACTIVE_NOT_RECRUITING

University of Leipzig

Leipzig, , Germany

Site Status RECRUITING

University of Mainz

Mainz, , Germany

Site Status RECRUITING

Minden Hospital

Minden, , Germany

Site Status RECRUITING

LMU University of Munich

Munich, , Germany

Site Status RECRUITING

Osnabrueck Hospital

Osnabrück, , Germany

Site Status RECRUITING

University Hospital of Regensburg

Regensburg, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Katja E Wartenberg, MD

Role: CONTACT

Phone: +493419720072

Email: [email protected]

Jürgen Meixensberger, MD PhD

Role: CONTACT

Phone: +493419717500

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rainer Kram, MD

Role: primary

Sarah Reitz, MD

Role: primary

Katja E Wartenberg, MD

Role: primary

Juergen Meixensberger, MD, PhD

Role: backup

Thomas Kerz, MD

Role: primary

Matthias Kruse, RN

Role: primary

Peter Schellinger, MD, PhD

Role: backup

Konstantinos Dimitriadis, MD, PhD

Role: primary

Moritz Schmidbauer, MD

Role: backup

Volker Schulte, MD

Role: primary

Sonja Kumpf, MD

Role: backup

Sylvia Bele, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

008/19-ek

Identifier Type: -

Identifier Source: org_study_id